Burkina Faso vs Thailand: Prevalence rate of hypertension in men aged 30-79
Burkina Faso
29.1
in 2019
Thailand
29.1
in 2019
Burkina Faso rank
178th
Thailand rank
178th
Prevalence rate of hypertension in men aged 30-79 over time
- Burkina Faso
- Thailand
How they compare
Burkina Faso currently reports 29.1 against 29.1 in Thailand, a difference of 0.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Burkina Faso ahead.
Burkina Faso ranks 178th and Thailand ranks 178th of 195 countries.
Burkina Faso has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burkina Faso | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 32.4 | 25.05 | 7.35 | Burkina Faso |
| 2000s | 32.86 | 27.31 | 5.55 | Burkina Faso |
| 2010s | 30.68 | 28.62 | 2.06 | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, Burkina Faso or Thailand?
- Burkina Faso, at 29.1 against 29.1 in Thailand as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between Burkina Faso and Thailand?
- 0, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Thailand?
- 30 years are reported by both, from 1990 to 2019.
- How do Burkina Faso and Thailand rank globally for prevalence rate of hypertension in men aged 30-79?
- Burkina Faso ranks 178th and Thailand ranks 178th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.